At meeting held on 23 July 2021
The Board of Jubilant Pharmova (JPM), at its meeting held on 23 July 2021, has approved the demerger of the Active Pharmaceutical Ingredients (API) undertaking of Jubilant Generics (JGL - a wholly owned subsidiary of the Company) and vesting of the same with JPM, on a going concern basis (Proposed Demerger), to be implemented through a scheme of arrangement between JGL and JPM and their respective shareholders and creditors under Sections 230 to 232 and other applicable provisions of the Companies Act, 2013 (Proposed Scheme).Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
